Cite
HARVARD Citation
Consoli, A. et al. (2018). A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment. Expert opinion on drug safety. 17 (3), pp. 293-302. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Consoli, A. et al. (2018). A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment. Expert opinion on drug safety. 17 (3), pp. 293-302. [Online].